Surgeons at the University of Maryland Medical Centre in the United States have achieved a successful second transplant of a genetically modified pig heart, this time for a 58-year-old patient namedLawrence Faucette, who suffered from end-stage heart disease.
Faucette received the pig heart transplant on September 20, following the first historic surgery performed on David Bennett in January 2022 by the same medical team from the University of Maryland Medicine.
Both groundbreaking surgeries were conducted by the faculty of the University of Maryland School of Medicine.
Faucette’s unique medical situation made this transplant his only viable option due to pre-existing peripheral vascular disease and internal bleeding complications.
According to the University of Maryland School of Medicine, Lawrence Faucette is now breathing on his own, and his heart is functioning well without the need for supportive devices.
Dr. Bartley Griffith, who performed the pig heart transplants for both patients, expressed gratitude to Faucette for his courage in advancing this medical field. Faucette, in response, expressed hope and a chance for a better future with this pioneering procedure.
